
Tazpure-Beta 50 Tablet ER
Marketer
Arrient Healthcare Pvt Ltd
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (50mg)
Overview Tazpure-Beta 50 Tablet ER
CardioBeta 50 Extended Release tablets manage hypertension, reducing the risk of strokes and heart attacks. Early use improves heart attack survival rates. For consistent blood levels, take CardioBeta 50 ER with food daily at the same time, continuing as prescribed. Don't discontinue treatment independently, even if feeling well, as hypertension is often asymptomatic; cessation can worsen your condition. Lifestyle modifications—exercise, weight management, and a healthy diet—further aid blood pressure control. Adhere to your physician's instructions. Potential side effects include headache, weakness, dizziness, hypotension (occasionally with fainting), shortness of breath, nausea, vomiting, stomach pain, fatigue, and elevated potassium levels. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolytes may be necessary. Inform your doctor of any kidney or liver issues before commencing treatment. Pregnant or breastfeeding individuals should seek medical counsel prior to use. Disclose all medications, especially those for hypertension or heart conditions.
Primary Ingredients of Tazpure-Beta 50 Tablet ER
No text provided. Please provide the text you wish me to rephrase.
Uses of Tazpure-Beta 50 Tablet ER
Managing Elevated Blood Pressure
Major Benefits of Tazpure-Beta 50 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Tazpure-Beta 50 Tablet ER with a meal.
Common Side effects of Tazpure-Beta 50 Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Tazpure-Beta 50 Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tazpure-Beta 50 Extended-Release Tablet should be administered with a meal.
How Tazpure-Beta 50 Tablet ER works:
Telmisartan and Metoprolol Succinate, combined in Tazpure-Beta 50 ER tablets, effectively reduce blood pressure.
SAFETY ADVICE
AlcoholUNSAFE
Combining Tazpure-Beta 50 Tablet ER and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Tazpure-Beta 50mg tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Tazpure-Beta 50mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Tazpure-Beta 50 tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Tazpure-Beta 50 tablets are considered safe for patients with renal impairment. No dosage modification is necessary for this medication in such patients.
LiverCAUTION
Patients with hepatic impairment should use Extended-release Tazpure-Beta 50mg tablets cautiously; dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Tazpure-Beta 50 Tablet ER :
Should you forget a dose of Tazpure-Beta 50 Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tazpure-Beta 50 Tablet ER
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Treatment Category | HEART |
